methylglucamine antimoniate

Small moleculeexperimental

Clinical trial activity

9 trials · 18 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
4
Phase 3
3
Phase 4
1

Earliest trial started Sep 1, 1995 (NCT00004755)

Timeline

1990s

  1. Jan 1, 1995

    Earliest Phase 2 Sponsor(trial)

2000s

  1. Jan 1, 2006

    Earliest Phase 3 Sponsor(trial)

Indications

Approved for

Mechanism of action

  • Unspecified targetUnclear

    Unclear

Chemistry & pharmacology

Mol. weight
365.98 g/mol
Chirality
Single Stereoisomer
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • 1-deoxy-1- (methylamino)glucitol antimonate(v)
  • glucantime
  • glucantime
  • meglumine antimonate
  • meglumine antimonate
  • meglumine antimonate
  • meglumine antimonate
  • meglumine antimoniate
  • meglumine antimoniate
  • meglumine antimoniate
  • meglumine antimoniate
  • meglumine antimony
  • methylglucamine antimonate
  • n-methylglucamine antimonate
  • n-methylglucamine antimoniate

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT01464242Phase 2/Phase 3 (Phase 3)Nov 1, 2011Centro Internacional de Entrenamiento e Investigaciones Médicas
NCT01310738Phase 4Feb 1, 2011Conselho Nacional de Desenvolvimento Científico e Tecnológico, Drugs for Neglected Diseases Initiative, Federal University of Minas Gerais, Federal University of Piaui, Federal University of Sergipe, Government of Brazil, Hospital Infantil Joao Paulo II - FHEMIG, State University of Montes Claros, University of Brasilia
NCT01377974Phase 2Jul 1, 2009University of Brasilia
NCT00682656Phase 2/Phase 3 (Phase 3)Jun 1, 2008Conselho Nacional de Desenvolvimento Científico e Tecnológico, Drugs for Neglected Diseases Initiative, Oswaldo Cruz Foundation
NCT00480883N/AJan 1, 2008Pakistan Army
NCT00600548Phase 2Jul 1, 2007AEterna Zentaris, Conselho Nacional de Desenvolvimento Científico e Tecnológico, Federal University of Bahia, Government of Spain
NCT00469495N/AFeb 1, 2007Federal University of Bahia
NCT00471705Phase 3Jun 1, 2006Universidad de Antioquia
NCT00004755Phase 2Sep 1, 1995Harvard University, National Institute of Allergy and Infectious Diseases (NIAID)
Showing 9 of 9 trials
Page 1 / 1

Organizations

Research & Development (18)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Conselho Nacional de Desenvolvimento Científico e TecnológicoGovernment3032007
Drugs for Neglected Diseases InitiativeAcademic/Hospital2022008
Federal University of BahiaAcademic/Hospital2222007
University of BrasiliaAcademic/Hospital2222009
AEterna ZentarisFor profit1012007
Centro Internacional de Entrenamiento e Investigaciones MédicasAcademic/Hospital1112011
Federal University of Minas GeraisAcademic/Hospital1012011
Federal University of PiauiAcademic/Hospital1012011
Federal University of SergipeAcademic/Hospital1012011
Government of BrazilGovernment1012011
Government of SpainGovernment1012007
Harvard UniversityAcademic/Hospital1011995
Hospital Infantil Joao Paulo II - FHEMIGAcademic/Hospital1012011
National Institute of Allergy and Infectious Diseases (NIAID)Government1111995
Oswaldo Cruz FoundationAcademic/Hospital1112008
Pakistan ArmyGovernment1112008
State University of Montes ClarosAcademic/Hospital1012011
Universidad de AntioquiaAcademic/Hospital1112006
18 organizations
Page 1 / 1